Latest news
Loading news…
ExploRNA Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Warsaw, Mazowieckie, Poland Founded 2019 11-50 employees For Profit
ExploRNA Therapeutics creates revolutionary advancements using mRNA as a therapeutic platform.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 29
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $513K
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 4
- HQ
- Warsaw, Mazowieckie, Poland
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.2
- Trend (90d)
- -0.2
2
professional contacts at ExploRNA Therapeutics
Contact execs at ExploRNA Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ExploRNA Therapeutics
Loading news…
FAQs about ExploRNA Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.